Healthcare Stocks Move in After-Market Session: Gainers and Losers

Several health care stocks moved in Wednesday's after-market session, with gains and losses reported. Accelerate Diagnostics AXDX stock rose 202.1% to $0.1, while Aytu BioPharma AYTU stock increased 53.33% to $2.07. Bionano Genomics BNGO stock rose 30.21% to $4.87, and ImmuCell ICCC stock rose 21.46% to $5.96. Losers included Onconetix ONCO stock, which declined 11.3% to $0.09, and Citius Pharmaceuticals CTXR stock, which decreased 7.25% to $0.87.

Wednesday's after-market session saw notable movements in several healthcare stocks. Accelerate Diagnostics (AXDX) experienced a significant rise, increasing by 202.1% to $0.1. Aytu BioPharma (AYTU) also saw a substantial gain, rising 53.33% to $2.07. Bionano Genomics (BNGO) and ImmuCell (ICCC) both reported gains of 30.21% and 21.46%, respectively, closing at $4.87 and $5.96. Conversely, Onconetix (ONCO) and Citius Pharmaceuticals (CTXR) faced declines, with Onconetix falling 11.3% to $0.09 and Citius Pharmaceuticals decreasing 7.25% to $0.87 [1].

These movements highlight the dynamic nature of the healthcare sector, which has been a defensive "port" in the face of recent market volatility, according to analysts [2]. The sector has shown resilience, outperforming the overall US stock market and many other sectors during the first quarter of 2025 [2].

References:

[1] https://finance.yahoo.com/sectors/healthcare/
[2] https://seekingalpha.com/article/4785976-invesco-health-care-fund-q1-2025-commentary